Low-Level Determination of Mutagenic Nitrosamine Impurities in Drug Substances by LC–MS/MS
July 12th 2021This article discusses the development of a series of applications that will allow for the determination of a number of nitrosamines that have been identified by the FDA as genotoxins to monitor, initially showing how to perform a separation of these compounds from the API and then looking at how MS can be applied to the analysis to ensure that the required detection limits can be reached.
Fast GC–MS for Analyzing Antioxidants and Industrial Food Analysis Applications
July 12th 2021LCGC Europe spoke to Hans-Gerd Janssen from the Unilever Foods Innovation Centre in The Netherlands, about the advantages of a novel, rapid method to analyze antioxidants that inhibit oxidation, and he explains that the maturity of GC technology is actually an advantage to the analyst.